DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Cytisine is an investigational drug.
There have been 14 clinical trials for Cytisine. The most recent clinical trial was a Phase 3 trial, which was initiated on October 13th 2020.
The most common disease conditions in clinical trials are Behavior, Addictive, Inflammation, and HIV Infections. The leading clinical trial sponsors are Achieve Life Sciences, University of Auckland, New Zealand, and Istituto Di Ricerche Farmacologiche Mario Negri.
There are three hundred US patents protecting this investigational drug and two international patents.
Recent Clinical Trials for Cytisine
|PeRiopEratiVE smokiNg cessaTion Trial||Population Health Research Institute||Phase 2/Phase 3|
|Cytisine Compared to Combination NRT in Relapsed Smokers||Ottawa Heart Institute Research Corporation||N/A|
|Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy||Mongolian National University of Medical Sciences||Phase 3|
Top disease conditions for Cytisine
Top clinical trial sponsors for Cytisine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Cytisine||⤷ Try it Free||Methods and compositions for treating infection||UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)||⤷ Try it Free|
|Cytisine||⤷ Try it Free||Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases||International Stem Cell Corporation (Carlsbad, CA)||⤷ Try it Free|
|Cytisine||⤷ Try it Free||Nicotinic attenuation of CNS inflammation and autoimmunity||Dignity Health (San Francisco, CA)||⤷ Try it Free|
|Cytisine||⤷ Try it Free||Dietary supplements and formulations||Eastern Vision Limited (Wanchai, HK)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Cytisine||World Intellectual Property Organization (WIPO)||WO2014052836||2032-09-27||⤷ Try it Free|
|Cytisine||European Patent Office||EP2961277||2033-02-15||⤷ Try it Free|
|Cytisine||Hong Kong||HK1215358||2033-02-15||⤷ Try it Free|
|Cytisine||Japan||JP2016508520||2033-02-15||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|